AKT1 and neoplasm: Here, we demonstrate that AM system blockade with αAM or αAMR disrupts endothelial cell junctions through rapid disengagement and inhibition of the VE-cadherin/β-catenin/Akt signalling pathway, leading to regression of tumor neovessels.